SOAM
GMAB icon

SBI Okasan Asset Management’s Genmab GMAB Stock Holding History

SBI Okasan Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$666K Hold
25,600
– – 0.02% 185
2026
Q1 		$661K Buy
25,600
+4,900
+24% +$147K 0.03% 161
2025
Q4 		$673K Buy
+20,700
New +$645K 0.04% 161

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SBI Okasan Asset Management's GMAB Position: Q2 2026 in Review

SBI Okasan Asset Management held its Genmab (GMAB) position steady in Q2 2026 at 25,600 shares worth $666K. The position accounts for 0.02% of the portfolio, ranked #185.

SBI Okasan Asset Management first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $673K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • SBI Okasan Asset Management held 25,600 shares of Genmab worth $666K as of Q2 2026.
  • SBI Okasan Asset Management left its Genmab share count unchanged in Q2 2026.
  • Genmab made up 0.02% of SBI Okasan Asset Management's portfolio in Q2 2026, its #185 holding.
  • SBI Okasan Asset Management first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • SBI Okasan Asset Management's Genmab position peaked at $673K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on SBI Okasan Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.